Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.[1] It is manufactured by MEDA Pharma and sold in Switzerland under the brand name Glutril.[2]
Glibornuride |
| Names |
|---|
| IUPAC name 1-(3-hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea |
| Identifiers |
|---|
CAS Number | - 26944-48-9

|
3D model (JSmol) | |
| ChemSpider | - 16735831

|
| DrugBank | - DB08962

|
| ECHA InfoCard | 100.043.735  |
| EC Number | |
| KEGG | - D02427

|
| MeSH | C073323 |
| |
| UNII | - VP83E7434R

|
InChI=1S/C18H26N2O4S/c1-11-5-7-12(8-6-11)25(23,24)20-16(22)19-14-13-9-10-18(4,15(14)21)17(13,2)3/h5-8,13-15,21H,9-10H2,1-4H3,(H2,19,20,22)/t13-,14+,15+,18+/m1/s1  Key: RMTYNAPTNBJHQI-LLDVTBCESA-N  InChI=1/C18H26N2O4S/c1-11-5-7-12(8-6-11)25(23,24)20-16(22)19-14-13-9-10-18(4,15(14)21)17(13,2)3/h5-8,13-15,21H,9-10H2,1-4H3,(H2,19,20,22)/t13-,14+,15+,18+/m1/s1 Key: RMTYNAPTNBJHQI-LLDVTBCEBZ
|
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2C3CCC(C2O)(C3(C)C)C
|
| Properties |
|---|
Chemical formula | C18H26N2O4S |
| Molar mass | 366.48 g/mol |
| Pharmacology |
|---|
ATC code | A10BB04 (WHO) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
verify (what is  ?) |
| Infobox references |
| |
SynthesisEdit
Glibornuride synthesis:[3] See also: U.S. Patent 3,770,761; eidem, U.S. Patent 3,654,357 (to Hoffmann-La Roche).
Gliburnide is an endo-endo derivative made from camphor-3-carboxamide by borohydride reduction (exo approach), followed by Hofmann rearrangement to carbamate, followed by displacement with sodium tosylamide.